“New Jersey is at an inflection point for cannabis beverages,” said Kim Sanchez Rael, CEO and co-founder of Azuca. “This is the first of its kind available in the state’s dispensaries, and it sets a new standard for how these products should perform — predictable, controlled and consistent in a format consumers already understand.”

The Cherry Hibiscus Elixir combines tart cherry, floral hibiscus and a touch of citrus, delivering a balanced, culinary-forward profile. Each 7.5-oz. serving contains 5 mg THC.

“For ButACake, it’s always been about flavor and premium experience,” Figaro said. “Working with the Azuca team has been a huge part of that. They continue to help us push the envelope in the fast-acting space and develop products that are both functional and genuinely enjoyable. This drink is an extension of that vision, something that feels elevated but easy, and brings a new kind of energy to how people engage with cannabis.”

Figaro has a longstanding partnership with Azuca as its inaugural Social Equity Fellow, part of an initiative designed to give emerging founders access to the tools and capabilities needed to scale. Through this collaboration, ButACake has worked closely with Azuca to bring precision-driven products to market, culminating in this commercial launch following a successful 2025 pilot.

The ButACake Cherry Hibiscus Elixir is now in full-scale production and available at Shipwreck’d Dispensary, Blue Oak Dispensary, Queen City and URB’N Dispensary & Consumption Lounge. Additional retail expansion is expected as distribution grows across the state. A Peach Elixir flavor will also be joining shelves in the coming weeks.